Pharmapro SA
Pharmapro reported total assets of €3.74m at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jul 2026).
The score of Pharmapro shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +7 % Total assets +15 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmapro's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
- Year ended 31 Dec 2024filed on 08 Jul 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
Pharmapro's financial analysis
- Solvency93.1%sector median: 53.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmapro
Pharmapro's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0461.179.570
- VAT number
- BE0461179570
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 22 Jul 1997
- Registered office
- 4700 Eupen
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Non-specialised wholesale trade (NACE 46900)
Pharmapro (SA) has been based in Eupen since 1997, active in: non-specialised wholesale trade. For 2025, it reports a net profit of 252,816 € and equity of €3.48m; its revenue is not published. Its solvency stands at 93.1%, above the median of its sector (53.5%).
Companies similar to Pharmapro
Companies in the same business, of comparable size and area, outside its group.
- Seuntjens G. - Geerts A. Ranst · balance sheet €3.74m
- Tillegem Activities of holding companies Knokke-Heist · balance sheet €3.74m
- Loomans Group Activities of holding companies Lommel · balance sheet €3.73m
- LA Forge Roussel Activities of holding companies Woluwe-Saint-Lambert · balance sheet €3.73m
- Pâris et Associés Intermediation service activities for passenger transportation Uccle · balance sheet €3.73m
- FMBG Passenger air transport Brussels · balance sheet €3.75m
- SDP Activities of holding companies Mortsel · balance sheet €3.73m
- Sophora Activities of holding companies Ghent · balance sheet €3.75m
Frequently asked questions about Pharmapro
What is the revenue of Pharmapro?
Pharmapro files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmapro?
In Belgium, the VAT number is the company number prefixed with BE: BE0461179570 for Pharmapro, if the company is VAT-registered. Its company number (CBE) is 0461.179.570.
Where is the registered office of Pharmapro?
According to the CBE register, the registered office of Pharmapro is in 4700 Eupen.
What is the equity of Pharmapro?
At the close of the 2025 financial year, the equity of Pharmapro amounts to 3,480,115 €, a solvency of 93.1% of total assets.
Who manages Pharmapro?
The register lists 6 active mandates at Pharmapro. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmapro
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →